AVAnita C. Volkers

Anita C. Volkers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anita C. Volkers has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Health disparities by occupation, modified by education: a cross-sectional population study

    by Anita C Volkers, Gert P Westert, Francois G Schellevis

    Socio-economic disparities in health status are frequently reported in research. By comparison with education and income, occupational status has been less extensively studied in relation to health status or the occurrence of specific chronic diseases. The aim of this study was to investigate health disparities in the working population based on occupational position and how they were modified by education.


  • Antidepressant use and off‐label prescribing in children and adolescents in Dutch general practice (2001–2005)

    by Anita C. Volkers, Eibert R. Heerdink, Liset van Dijk

    Purpose: To study the use of antidepressants in children and adolescents in Dutch general practice in 2001 and 2005 and to determine off‐label prescribing.Methods: Data were obtained from the Netherlands Information Network of General Practice (LINH) that comprised 97 practices in 2001 and 73 practices in 2005. General practitioners (GPs) recorded prescriptions with their indication in the medical records of the patients during one calendar year. We selected boys and girls aged 0–17 years (n = 83 442 in 2001; n = 62 969 in 2005) and identified those who got prescribed antidepressants (N06A). Prevalence of use, indications and percentage of off‐label prescriptions were compared between 2001 and 2005.Results: The prevalence of selective serotonin reuptake inhibitor (SSRI) use decreased from 1.2 to 1.1 per 1000 children and adolescents between 2001 and 2005. The use of tricyclic antidepressants (TCAs) and other antidepressants also decreased (0.8 to 0.7 and 0.3 to 0.2, respectively). TCAs were often prescribed for nocturnal enuresis, but in patients aged 12–17 years hyperactivity was the leading indication in both years. GPs continued to prescribe SSRIs for depression (about half of the prescriptions) after the safety warnings, while venlafaxine prescribed for depression decreased in favour of anxiety. Off‐label prescribing of SSRIs increased from 16.7% to 34.4% and that of venlafaxine from 22.2% to 58.3%. All SSRI and venlafaxine prescriptions were unlicensed for age.Conclusions: The decreased use of SSRIs and venlafaxine suggests an impact of the safety warnings. A point of concern is the enlarged off‐label prescribing and insight in the underlying reasons and its appropriateness is needed. Copyright © 2007 John Wiley & Sons, Ltd.


  • Welke overwegingen heeft de huisarts om antidepressiva voor te schrijven?

    by Anita Volkers, Liset van Dijk, Annemarie de Jong, Dinny de Bakker

  • Open Access

    Track 3: Social status, work, and morbidity

    by Anita C Volkers, G P Westert, F G Schellevis, Serena Bartys, A K Burton, C J Main

    Track 3: Social status, work, and morbidity, European Journal of Public Health, Volume 15, Issue suppl_1, 1 October 2005, Pages 62–63, https://doi.org/10.1093/e

  • The problem of diagnosing major depression in elderly primary care patients

    by Anita C. Volkers, Jasper Nuyen, Peter F.M. Verhaak, François G. Schellevis


  • Effects of Imipramine, Fluvoxamine and Depressive Mood on Autonomic Cardiac Functioning in Major Depressive Disorder

    by A. C. Volkers, J. H. M. Tulen, W. W. van Den Broek, J. A. Bruyn, J. Passchier, L. Pepplinkhuizen

    Objective: Diminished HR variability is considered to be associated with depression and the increased risk of cardiovascular disease. The pharmacological effects of antidepressants and depressive mood itself may contribute to alterations in autonomic cardiac functioning, but a limited amount of data is available. We studied the effects of two different types of antidepressant treatments (imipramine and fluvoxamine), in addition to the effect of depressive mood, on the cardiovascular system in depressed patients. Methods: Depressed inpatients were studied during a drug-free period and after 4 weeks of adequate treatment with imipramine (n = 17) or fluvoxamine (n = 24). Heart rate variability, blood pressure variability, and a baroreflex sensitivity index during supine rest and orthostatic challenge were analyzed by means of spectral techniques to obtain noninvasive parameters of sympathetic and parasympathetic activity. Results: Both imipramine and fluvoxamine reduced sympathetic and parasympathetic activity, although the effects of imipramine were much more pronounced. Severity of depression was positively related to mean levels of heart rate and blood pressure in the total patient group. There was no convincing evidence that these relationships differed between depressed patients treated with imipramine and those treated with fluvoxamine. Conclusion: Our findings suggest that alterations in mean heart rate and blood pressure in depressed patients after antidepressant treatment are the result of a combined effect of pharmacological actions of antidepressants and improvement of depressive mood state. The present study did not confirm the relationship between clinical state and cardiovascular variability or baroreflex sensitivity.